Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Secondary listing

The Chinese drug developer put a rocket booster under its share price after enlisting a Japanese rival as a new equity partner and unveiling plans for a U.S. listing.

Ascentage Pharma soars on deal with cancer drug competitor

The Chinese drug developer put a rocket booster under its share price after enlisting a Japanese rival as a new equity partner and unveiling plans for a U.S. listing Key…
June 27, 2024
6855.HK

FAST NEWS:  Tianqi Lithium Forecasts Huge Profit Jump for 2022

The Latest: Tianqi Lithium Corp. (9696.HK; 002466.SZ) announced on Wednesday it expects to report its net profit soared between 1,011% and 1,131% to between 23.1 billion yuan ($3.4 billion) and…
January 19, 2023

FAST NEWS: ZTO’s Hong Kong New ‘Primary’ Listing Status to Take Effect in May

The Latest: Logistics company ZTO Express (Cayman) Inc. (ZTO.US; 2057.HK) said its application to upgrade its Hong Kong listing from “secondary” to “primary” status has been approved and is expected…
December 27, 2022

FAST NEWS: Yum China Shifts Hong Kong Listing to Primary Status

The latest: Yum China Holdings, Inc. (YUMC.US; 9987.HK), operator of U.S. fast food giant Yum Brands Inc.’s (YUM.US) KFC and Pizza Hut chains in China, on Wednesday announced it will convert its secondary…
October 20, 2022

FAST NEWS: Tencent Music’s Hong Kong Shares Outshine New York in Trading Debut

The latest: Tencent Music Entertainment Group (TME.US; 1698.HK) listed on the Hong Kong Stock Exchange Wednesday using a method called “by way of introduction,” which does not involve issuing new…
September 21, 2022

FAST NEWS: Noah Seeks to Upgrade Hong Kong Listing Status

The latest: Noah Holdings Private Wealth and Asset Management Ltd. (NOAH.US; 6686.HK) announced Wednesday that its board has approved allowing the company to convert its Hong Kong listing from secondary…
August 11, 2022

Wealth Manager Noah Banks on Hong Kong to Revive Fortunes

The Chinese financial firm serving high-net-worth investors will soon list on the Hong Kong Stock Exchange to fund its business expansion. (more…)
June 29, 2022
Load more

Recent Articles

The Chinese drug developer put a rocket booster under its share price after enlisting a Japanese rival as a new equity partner and unveiling plans for a U.S. listing.
June 27, 2024

Ascentage Pharma soars on deal with cancer drug competitor

6855.HK
January 19, 2023

FAST NEWS:  Tianqi Lithium Forecasts Huge Profit Jump for 2022

December 27, 2022

FAST NEWS: ZTO’s Hong Kong New ‘Primary’ Listing Status to Take Effect in May

October 20, 2022

FAST NEWS: Yum China Shifts Hong Kong Listing to Primary Status

September 21, 2022

FAST NEWS: Tencent Music’s Hong Kong Shares Outshine New York in Trading Debut

August 11, 2022

FAST NEWS: Noah Seeks to Upgrade Hong Kong Listing Status

June 29, 2022

Wealth Manager Noah Banks on Hong Kong to Revive Fortunes

RELATED ARTICLES

  1. December 24, 2024
    BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
    6855.HK
  2. January 9, 2025
    Cancer drug maker Genfleet joins Hong Kong IPO influx
  3. December 12, 2024
    Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
  4. January 24, 2025
    BRIEF: Ascentage Pharma prices U.S. IPO at 20% discount, to raise up to $130 million
    6855.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.